Skip to main content
OpenTrials

Clinical trial condition

Blood-Borne Infections

Explore clinical trials studying Blood-Borne Infections. Study availability and eligibility vary by location and protocol.

8,267 public trials 445 recruiting studies
Refine in advanced search Browse all conditions

Blood-Borne Infections trial results

Completed

Evaluating the Safety and Pharmacokinetics of Raltegravir in Infants

NCT01828073

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • University of California, UC San Diego CRS- Mother-Child-Adolescent HIV Program La Jolla, California, United States
  • Miller Children's Hosp. Long Beach CA NICHD CRS Long Beach, California, United States
  • Usc La Nichd Crs Los Angeles, California, United States
  • David Geffen School of Medicine at UCLA NICHD CRS Los Angeles, California, United States
View all 19 locations
View Trial Details
Completed

Pegylated Interferon Alfa-2a Maintenance Therapy and Liver Disease Progression in People Infected With Both HIV and Hepatitis C Virus (HCV)

NCT00078403

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +18 more
Locations
  • Alabama Therapeutics CRS Birmingham, Alabama, United States
  • University of Southern California CRS Los Angeles, California, United States
  • UCLA CARE Center CRS Los Angeles, California, United States
  • Stanford AIDS Clinical Trials Unit CRS Palo Alto, California, United States
View all 37 locations
View Trial Details
Completed

BufferGel and PRO 2000/5: Vaginal Gels to Prevent HIV Infection in Women

NCT00074425

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • 3535 Market Street CRS Philadelphia, Pennsylvania, United States
  • University of North Carolina Lilongwe CRS Lilongwe, Central Region, Malawi
  • College of Med. JHU CRS Blantyre, Southern Region, Malawi
  • Chatsworth CRS Chatsworth, KwaZulu-Natal, South Africa
View Trial Details
Completed

A Safety and Immune Response Study of 2 Experimental HIV Vaccines

NCT02404311

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • CAPRISA eThekwini CRS Durban, KwaZulu-Natal, South Africa
  • Isipingo CRS Durban, KwaZulu-Natal, South Africa
  • Emavundleni Desmond Tutu HIV Centre CRS Cape Town, Western Cape, South Africa
  • Aurum Institute for Health Research Klerksdorp, South Africa
View Trial Details
Completed

Preventing Sexual Transmission of HIV With Anti-HIV Drugs

NCT00074581

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Fenway Community Health Ctr. CRS Boston, Massachusetts, United States
  • Gaborone CRS Gaborone, Botswana
  • Hospital Geral de Nova Iguaçu CRS (HGNI CRS) Nova Iguaçu, Rio de Janeiro, Brazil
  • Hospital Nossa Senhora da Conceicao CRS Port Alegre, Rio Grande do Sul, Brazil
View all 17 locations
View Trial Details
Completed

Atazanavir Used in Combination With Other Anti-HIV Drugs in HIV-Infected Infants, Children, and Adolescents

NCT00006604

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • UAB Pediatric Infectious Diseases CRS Birmingham, Alabama, United States
  • Usc La Nichd Crs Alhambra, California, United States
  • University of California, UC San Diego CRS La Jolla, California, United States
  • Miller Children's Hosp. Long Beach CA NICHD CRS Long Beach, California, United States
View all 36 locations
View Trial Details
Completed

Safety, Tolerance and Pharmacokinetics of Raltegravir-Containing Antiretroviral Therapy in Infants, Children Infected With HIV and TB

NCT01751568

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +17 more
Locations
  • Soweto IMPAACT CRS Johannesburg, Gauteng, South Africa
  • Wits RHI Shandukani Research Centre CRS Johannesburg, Gauteng, South Africa
  • Desmond Tutu TB Centre - Stellenbosch University (DTTC-SU) CRS Cape Town, Western Cape, South Africa
  • Famcru Crs Cape Town, Western Cape, South Africa
View Trial Details
Completed

Reducing the Incidence of Nevirapine Resistance Mutations in Pregnant HIV Infected Women Who Receive Anti-HIV Drugs Prior to and After Giving Birth

NCT00109590

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Bhumibol Adulyadej Hosp. CRS Saimai, Bangkok, Thailand
  • Siriraj Hospital Mahidol University CRS Bangkok, Bangkoknoi, Thailand
  • Prapokklao Hosp. CRS Chanthaburi, Thailand
  • Chiang Mai University Pediatrics-Obstetrics CRS Chiang Mai, Thailand
View Trial Details

Related conditions